What's new in surgical oncology

Journal of the American College of Surgeons

Volumn 192, Issue 5, 2001, Pages 624-639

  Leitch, A Marilyn ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BREAST CANCER; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; HUMAN; LYMPH NODE BIOPSY; MELANOMA; ONCOLOGY; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SARCOMA; SENTINEL LYMPH NODE; STOMACH CANCER;

EID: 0035002448     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(01)00846-8     Document Type: Article

References (56)

1. The annual report to the nation on the status of cancer, 1973-97, with a special section on colorectal cancer
2. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: Improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid
3. Subareolar versus peritumoral injection for location of the sentinel node
4. Lymphatic mapping in breast cancer using subareolar injection of blue dye
5. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer
6. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer
7. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used
8. The sentinel node in breast cancer: A multi-center validation study
9. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node negative breast cancer
10. Sentinel node biopsy in ductal carcinoma in situ
11. Sentinel node biopsy: Is it indicated in patients with high risk ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
12. The consensus conference on the treatment of the in situ ductal carcinoma of the breast, April 22-25, 1999
13. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer
14. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma
15. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3NOMO breast cancer
16. Should internal mammaty nodes be sampled in the sentinel lymph node era?
17. Credentialing issues with sentinel lymph node staging for breast cancer
18. Outcome at 8 years after breast conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence
19. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomized phase III trial 10853
20. Lumpectomy and radiation for the treatment of intraductal breast cancer: Findings from national surgical adjuvant breast and bowel project B-17
21. Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1/2 mutations
22. Technical aspects of intraoperative mapping for early stage melanoma
23. Judging the therapeutic value of lymph node dissections for melanoma
24. Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?
25. Sentinel lymph node biopsy in cutaneous melanoma: The WHO melanoma program experience
26. Incidence of sentinel node metastasis in patients with thin primary melanoma (≤ 1 mm) with vertical growth phase
27. Model predicting survival in Stage I melanoma based on tumor progression
28. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (≥4mm) primary melanoma
29. The augsburg consensus: Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies
30. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm)
31. Interferon alfa-2b adjuvant therapy of high risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
32. High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of Intergroup Trial E1690/S9111/C9190
33. Positron emission tomography scanning in malignant melanoma: Clinical utility in patients with stage III disease
34. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
35. Cancer statistics, 2000
36. Risk of advanced proximal neoplasms in asymptomatic adults according to distal colorectal findings
37. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy
38. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
39. Primary care: Chemoprevention of colorectal cancer
40. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging
41. Lymph node micrometastases do not predict relapse in stage II colon cancer
42. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
43. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National surgical adjuvant breast and bowel project protocol R-02
44. Postoperative colorectal surveillance
45. 2000 Update of american society of clinical oncology colorectal cancer surveillance guidelines
46. Survival after resection of multiple hepatic colorectal metastases
47. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications
48. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors
49. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas
50. Current follow-up strategies after potentially curative resection of extremity sarcomas
51. Influence of biologic factors and anatomic site in completely resected liposarcoma
52. Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas
53. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy
54. Outcome of prophylactic radical lymphadenectomy with gastrectomy in patients with early gastric carcinoma without lymph node metastasis
55. Radio-guided sentinel node navigation surgery for gastrointestinal (esophageal, gastric and colorectal) cancers
56. Intra-operative identification of sentinel lymph nodes in patients with early gastric cancer